celdoxome pegylated liposomal
yes pharmaceutical development services gmbh - doxorubicinhydroklorid - breast neoplasms; ovarian neoplasms; multiple myeloma; sarcoma, kaposi - antineoplastiska medel - celdoxome pegylated liposomal is indicated in adults:as monotherapy for patients with metastatic breast cancer, where there is an increased cardiac risk. or treatment of advanced ovarian cancer in women who have failed a first-line platinum-based chemotherapy regimen. in combination with bortezomib for the treatment of progressive multiple myeloma in patients who have received at least one prior therapy and who have already undergone or are unsuitable for bone marrow transplant. for treatment of aids-related kaposi’s sarcoma (ks) in patients with low cd4 counts (< 200 cd4 lymphocytes/mm3) and extensive mucocutaneous or visceral disease. celdoxome pegylated liposomal may be used as first-line systemic chemotherapy, or as second line chemotherapy in aids-ks patients with disease that has progressed with, or in patients intolerant to, prior combination systemic chemotherapy comprising at least two of the following agents: a vinca alkaloid, bleomycin and standard doxorubicin (or other anthracycline).
amlodipin heumann 10 mg tablett
yes pharmaceutical development services gmbh - amlodipinmaleat - tablett - 10 mg - laktosmonohydrat hjälpämne; amlodipinmaleat 12,8 mg aktiv substans - amlodipin
amlodipin heumann 5 mg tablett
yes pharmaceutical development services gmbh - amlodipinmaleat - tablett - 5 mg - amlodipinmaleat 6,4 mg aktiv substans; laktosmonohydrat hjälpämne - amlodipin
estradurin 80 mg pulver och vätska till injektionsvätska, lösning
pharmanovia a/s - mepivakainhydroklorid; polyestradiolfosfat - pulver och vätska till injektionsvätska, lösning - 80 mg - mepivakainhydroklorid 5 mg aktiv substans; polyestradiolfosfat 80 mg aktiv substans - polyöstradiolfosfat
alacare 8 mg medicinskt plåster
photonamic gmbh & co. kg - aminolevulinsyrahydroklorid - medicinskt plåster - 8 mg - aminolevulinsyrahydroklorid 10,224 mg aktiv substans - aminolevulinsyra
axiago 20 mg enterotablett
grünenthal gmbh - esomeprazolmagnesiumtrihydrat - enterotablett - 20 mg - natriumlaurilsulfat hjälpämne; sockersfärer hjälpämne; esomeprazolmagnesiumtrihydrat 22,3 mg aktiv substans - esomeprazol
axiago 40 mg enterotablett
grünenthal gmbh - esomeprazolmagnesiumtrihydrat - enterotablett - 40 mg - esomeprazolmagnesiumtrihydrat 44,5 mg aktiv substans; sockersfärer hjälpämne; natriumlaurilsulfat hjälpämne - esomeprazol
levetiracetam tad 1000 mg filmdragerad tablett
tad pharma gmbh - levetiracetam - filmdragerad tablett - 1000 mg - levetiracetam 1000 mg aktiv substans - levetiracetam
levebon 1000 mg filmdragerad tablett
g.l. pharma gmbh - levetiracetam - filmdragerad tablett - 1000 mg - levetiracetam 1000 mg aktiv substans - levetiracetam
levetiracetam tad 250 mg filmdragerad tablett
tad pharma gmbh - levetiracetam - filmdragerad tablett - 250 mg - levetiracetam 250 mg aktiv substans - levetiracetam